Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for awake intubation in difficult airway
ChiCTR2100050502Phase 4Recruiting
- Sponsor
- The Affiliated Stomatological Hospital of GuangXi Medical University
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and dexmedetomidine in difficult airway (3 arms), sponsored by The Affiliated Stomatological Hospital of GuangXi Medical University. Primary endpoint: sedation success rate. Started Sep 2021; status: recruiting.
02
Drugs
remimazolamdexmedetomidine
03
Conditions
difficult airway
Beyond the preview
Go deeper on ChiCTR2100050502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050502.